Home
KALA
KALA News

Latest KALA BIO Inc. (KALA) News on October 8, 2025

KALA BIO, Inc.'s (NASDAQ:KALA) market cap surged US$28m last week, retail investors who have a lot riding on the company were rewarded

Simply Wall St.

a month ago

KALA BIO, Inc.'s (NASDAQ:KALA) market cap surged US$28m last week, retail investors who have a lot riding on the company were rewarded

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

GlobeNewswire

3 months ago

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

KALA BIO to Present at Jefferies Global Healthcare Conference

GlobeNewswire

4 months ago

KALA BIO to Present at Jefferies Global Healthcare Conference

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

5 months ago

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

KALA BIO to Present at TD Cowen 45th Annual Health Care Conference

GlobeNewswire

7 months ago

KALA BIO to Present at TD Cowen 45th Annual Health Care Conference

KALA BIO Announces Chief Executive Officer Transition

GlobeNewswire

8 months ago

KALA BIO Announces Chief Executive Officer Transition

KALA BIO Announces $10,750,000 Private Placement

GlobeNewswire

9 months ago

KALA BIO Announces $10,750,000 Private Placement

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire

10 months ago

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference

KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update

KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

GlobeNewswire

a year ago

KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update

KALA BIO Announces $12,500,000 Private Placement

GlobeNewswire

a year ago

KALA BIO Announces $12,500,000 Private Placement

KALA BIO to Present at Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

KALA BIO to Present at Jefferies Global Healthcare Conference

Wall Street Analysts Just Trimmed Price Target for KALA BIO, Inc. (NASDAQ:KALA)

Insider Monkey

a year ago

Wall Street Analysts Just Trimmed Price Target for KALA BIO, Inc. (NASDAQ:KALA)

KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference

GlobeNewswire

2 years ago

KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference

KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

2 years ago

KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Idaho Strategic CEO and President to Speak at U.S. Department of Energy's Critical Minerals Workshop

ACCESSWIRE

2 years ago

Idaho Strategic CEO and President to Speak at U.S. Department of Energy's Critical Minerals Workshop

GlobeNewswire

2 years ago

Comscore and Nexstar Reach Multi-Year Agreement for Linear and Cross-Platform Audience Measurement

Xos, Inc. Ranked Number 51 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

GlobeNewswire

2 years ago

Xos, Inc. Ranked Number 51 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Analysts Expect comScore, Inc. (NASDAQ:SCOR) To Breakeven Soon

Simply Wall St.

2 years ago

Analysts Expect comScore, Inc. (NASDAQ:SCOR) To Breakeven Soon

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for December 2023

GlobeNewswire

2 years ago

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for December 2023

Phoenix Completes Purchase of Proterra's Transit Business

ACCESSWIRE

2 years ago

Phoenix Completes Purchase of Proterra's Transit Business

Phoenix’s EdisonFuture Plans to Accept Payment in Bitcoin

ACCESSWIRE

2 years ago

Phoenix’s EdisonFuture Plans to Accept Payment in Bitcoin

Web3 Winners: 3 Stocks to Invest in the Decentralized Web

InvestorPlace

2 years ago

Web3 Winners: 3 Stocks to Invest in the Decentralized Web

Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength

Zacks

2 years ago

Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for November 2023

GlobeNewswire

2 years ago

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for November 2023

Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories

Business Wire

2 years ago

Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories

Workhorse Group Receives First Fleet Order for W56 Step Van

GlobeNewswire

2 years ago

Workhorse Group Receives First Fleet Order for W56 Step Van

Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations

GlobeNewswire

2 years ago

Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations

The 3 Most Undervalued Penny Stocks to Buy in December

InvestorPlace

2 years ago

The 3 Most Undervalued Penny Stocks to Buy in December

Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations

PR Newswire

2 years ago

Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations

Idaho Strategic's Mineral Hill Sample Returns 34% Total Rare Earth Oxides (TREO)

ACCESSWIRE

2 years ago

Idaho Strategic's Mineral Hill Sample Returns 34% Total Rare Earth Oxides (TREO)

Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire

2 years ago

Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock

Business Wire

2 years ago

Graphite for North America Graphex Group Receives Unsolicited Preliminary Offer and LOI to Buy Graphex Technologies and Propel its North American Expansion Strategy

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

GlobeNewswire

2 years ago

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

Is It Smart To Buy First US Bancshares, Inc. (NASDAQ:FUSB) Before It Goes Ex-Dividend?

Simply Wall St.

2 years ago

Is It Smart To Buy First US Bancshares, Inc. (NASDAQ:FUSB) Before It Goes Ex-Dividend?

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

GlobeNewswire

2 years ago

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial

GlobeNewswire

2 years ago

Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial

Kronos Bio Up 47%, Insider Buyers Are Up 31%

Simply Wall St.

2 years ago

Kronos Bio Up 47%, Insider Buyers Are Up 31%

Hycroft Drills Best Hole Ever - Discovers New High-Grade Silver System

PR Newswire

2 years ago

Hycroft Drills Best Hole Ever - Discovers New High-Grade Silver System

Squatty Potty Re-Launches In Walmart Stores Nationwide

GlobeNewswire

2 years ago

Squatty Potty Re-Launches In Walmart Stores Nationwide

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights

GlobeNewswire

2 years ago

Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript

RumbleON, Inc. (NASDAQ:RMBL) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

RumbleON, Inc. (NASDAQ:RMBL) Q3 2023 Earnings Call Transcript

Allied Gaming & Entertainment to Report Third Quarter 2023 Results on Thursday, November 9th

Business Wire

2 years ago

Allied Gaming & Entertainment to Report Third Quarter 2023 Results on Thursday, November 9th

Share on Social Networks: